Company / Current Liabilities
AbbVie Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$43.3B
FY2025
5-year range
$29.5B / $43.3B
FY2021-FY2025
Trend
+11.7%
vs FY2024
Sector context
#2 of 215
Health Care
What the data says
Among 215 Health Care companies, AbbVie is in the bottom 1% for current liabilities. Current Liabilities has increased for 3 consecutive years, from $29.5B in FY2022 to $43.3B in FY2025.
Based on SEC 10-K filings.
$43.3B in FY2025 with a 5-year CAGR of +8.6%. Ranks 2nd among 215 companies in Health Care.
Increased from $37.8B to $43.3B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +13.6%
- 5-Year CAGR
- +8.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 215This company $43.3B Sector average $1.6B
▼
+2648.6% above sector average
Key checks
Key Insights
- AbbVie's current liabilities has grown for 3 consecutive years.
- 5-year CAGR of +8.6%, indicating consistent growth.
- In FY2025, current liabilities increased 11.7% year-over-year.
- Ranks #2 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.3B | +11.7% |
| FY2024 | $38.7B | +2.4% |
| FY2023 | $37.8B | +28.1% |
| FY2022 | $29.5B | -16.1% |
| FY2021 | $35.2B | +22.8% |
| FY2020 | $28.7B | +83.9% |
| FY2019 | $15.6B | -9.6% |
| FY2018 | $17.2B | +3.6% |
| FY2017 | $16.6B | +70.1% |
| FY2016 | $9.8B | -10.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026